
Meghmani Organics Limited Approves Amalgamation of Subsidiaries
Meghmani Organics Limited, the Transferee Company, announced that its Board of Directors, at a meeting on April 4, 2026, approved a Draft Scheme of Amalgamation. The Scheme details the amalgamation of two wholly owned subsidiaries: Kilburn Chemicals Limited (Transferor Company 1) and Meghmani Crop Nutrition Limited (Transferor Company 2), into Meghmani Organics Limited.The amalgamation is structured in accordance with Sections 230 to 232 of the Companies Act, 2013, and is designed to simplify the overall group structure by integrating the operations of the Transferor Companies into the Transferee Company.
Subsidiary Details
The two transferring entities are fully owned subsidiaries of Meghmani Organics Limited.| Company Name | Role | CIN | Primary Business |
|---|---|---|---|
| Kilburn Chemicals Limited | Transferor Company 1 | U24117GJ1990PLC135801 | Manufacturing and selling Anatase Grade Titanium Dioxide in India. |
| Meghmani Crop Nutrition Limited | Transferor Company 2 | U24110GJ2021PLC119809 | Manufacturing and selling of crop nutrition products. |
Meghmani Organics Limited, the Transferee Company, is engaged in the business of manufacturing and selling Crop protection products and Pigments. Its equity shares are listed on the BSE Limited and National Stock Exchange of India Limited.
Objectives and Rationale
The Board stated that the amalgamation supports the Transferee Company’s business acquisition strategy. The objectives of the Scheme include:- Simplifying the group structure by fully integrating operations.
- Optimally utilizing existing resources through the consolidation of operations into a single legal entity.
- Providing an opportunity to leverage and pool resources.
- Deriving operational and financial synergies through cost reduction and prudent financial management.
- Achieving better administration and focused operational efforts by eliminating duplication.
Share Capital Structure
The Scheme outlines the share capital details for all three entities as of March 31, 2025.For Kilburn Chemicals Limited (Transferor Company 1):
- Authorized Equity Shares: 1,60,00,000 equity Shares of Rs. 10 each (Total: 16,00,00,000)
- Authorized Preference Shares: 4,00,000 Cumulative Redeemable Preference Shares of Rs 100 each (Total: 4,00,00,000)
- Issued, Subscribed and Paid-Up Equity Shares: 1,21,50,000 equity Shares of Rs. 10 each (Total: 12,15,00,000)
For Meghmani Crop Nutrition Limited (Transferor Company 2):
- Authorized Equity Shares: 50,00,000 equity Shares of Rs. 10 each (Total: 5,00,00,000)
- Authorized Preference Shares: 3,50,00,000 Cumulative Redeemable Preference Shares of Rs 10 each (Total: 35,00,00,000)
- Issued, Subscribed and Paid-Up Equity Shares: 10,50,000 equity Shares of Rs. 10 each (Total: 1,05,00,000)
For Meghmani Organics Limited (Transferee Company):
- Authorized Equity Shares: 37,00,00,000 Equity Shares of Rs.1/- each (Total: 37,00,00,000)
- Issued, subscribed and fully paid-up Equity Shares: 25,43,14,211 Equity Shares of Rs.1/- each (Total: 25,43,14,211)
Implications of the Amalgamation
Under the Scheme, assets, undertakings, properties, and liabilities of the Transferor Companies are to stand transferred to and vest in the Transferee Company. All contracts, deeds, and associated rights and obligations are deemed to transfer to the Transferee Company.Regarding the share capital, the authorized share capital of the Transferee Company is set to increase automatically upon the Scheme becoming effective.
| Authorized Share Capital | Amount (Rs.) |
|---|---|
| 97,00,00,000 Equity Share of Rs. 1 Each | 97,00,00,000 |
The Transferee Company will account for the amalgamation using the Pooling of Interest Method of accounting under Indian Accounting Standard (Ind AS) 103.
Upon the Scheme becoming effective, the Transferor Companies are slated to stand dissolved without being wound up.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.